Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Benjamin L. Cohen"'
Publikováno v:
Journal of Clinical Gastroenterology. 52:333-338
BACKGROUND AND GOALS: Despite published clinical guidelines, substantive data underlying the approach to the management of hospitalized ulcerative colitis (UC) patients failing outpatient therapy are lacking. Variability in practice is therefore not
Autor:
Ryan C. Ungaro, Louis J. Cohen, Marc Fenster, Robert Hirten, Ashish Atreja, Zane Gallinger, Benjamin L. Cohen, Jean-Frederic Colombel, Saurabh Mehandru
Inflammatory bowel disease (IBD) therapy often requires biologic medications delivered by intravenous infusion.1-4 Historically, intravenous infusions of infliximab and vedolizumab in patients with IBD were delivered under direct supervision of clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91dc0d1ff218edefcf4bff53dbbe9aab
https://europepmc.org/articles/PMC7026825/
https://europepmc.org/articles/PMC7026825/
Publikováno v:
Clinical Gastroenterology and Hepatology. 14:71-79
Background & Aims There have been reports of an association between Crohn's disease and hidradenitis suppurativa, a chronic, relapsing, inflammatory condition of the skin. We investigated features of hidradenitis suppurativa in patients with Crohn's
Autor:
Shradha Agarwal, Jean-Frederic Colombel, Steven Hendler, Benjamin L. Cohen, Bruce E. Sands, Lloyd Mayer
Publikováno v:
Journal of Crohn's and Colitis. 9:266-275
Background: Inadequate response to infliximab \[IFX] therapy in Crohn’s disease [CD] may necessitate dose intensification. We evaluated safety and efficacy of high-dose IFX [HD IFX\] \[greater than 10mg/kg every 8 weeks\] in CD and characterized pr
Autor:
Benjamin L. Cohen, Steven Naymagon, Marla Dubinsky, Bruce E. Sands, Shailja C. Shah, Hinaben J. Panchal
Publikováno v:
Inflammatory bowel diseases. 24(3)
Background Standard outpatient induction dosing of infliximab (IFX) may not be effective in hospitalized ulcerative colitis (UC) patients with higher inflammatory burden and colectomy risk. Our aim was to determine whether initial IFX induction dose
Autor:
David B. Sachar, Benjamin L. Cohen
Publikováno v:
BMJ (Clinical research ed.). 357
The treatment of inflammatory bowel disease (IBD)-ulcerative colitis (UC) and Crohn's disease (CD)-has evolved beyond surgery with the introduction of biologic agents, primarily antibodies against mediators of inflammation and cell attraction. Anti-t
Autor:
Bruce E. Sands, Hinaben J. Panchal, Benjamin L. Cohen, Marla Dubinsky, Sanchit Gupta, Steven Naymagon, Shailja C. Shah
Publikováno v:
Gastroenterology. 152:S396
Publikováno v:
Gastroenterology. 150:S813
Publikováno v:
Inflammatory Bowel Diseases. 19:S22-S23
Autor:
Steven Hendler, Lloyd Mayer, Bruce E. Sands, Benjamin L. Cohen, Jean-Frederic Colombel, Shradha Agarwal
Publikováno v:
American Journal of Gastroenterology. 108:S503